Stock Taper Revenue: $59.3 million, down from $89.2 million year-over-year, primarily due to the transition of certain programs to small business set-aside contracts.
Adjusted EBITDA: $5.3 million, compared to $9.4 million in the prior-year period, reflecting the revenue decline.
Adjusted EBITDA Margin: 9%, adjusted for cost-scaling initiatives.
Free Cash Flow: Approximately $3.8 million generated during the quarter.
Total Debt: Reduced to $132.7 million from $136.6 million, continuing a trend of deleveraging.
The federal funding environment is improving, with increased budget visibility and funding for key health and defense agencies.
DLH Holdings Corp. is experiencing a resurgence in bidding activity, with several key procurements expected to be awarded in the coming months.
The company was awarded a two-year sole-source extension for a contract with the National Institutes of Health (NIH), enhancing revenue visibility.
Continued focus on digital transformation, cybersecurity, and advanced technologies aligns with government priorities and DLH’s strategic pillars.
Management expresses optimism about the upcoming fiscal year, anticipating a healthy pipeline of opportunities and potential contract awards.
The company expects to convert 50% to 55% of EBITDA generated during fiscal 2026 into debt reduction.
There is cautious optimism regarding the timely awarding of contracts despite potential government shutdown risks, with several RFPs already submitted.
Revenue decline attributed to the transition of contracts to small business set-asides, particularly impacting the VA CMOP and Head Start programs.
The company faces ongoing risks related to government procurement delays, particularly around the September budget deadline and potential continuing resolutions.
There is uncertainty regarding future federal health spending, which could pose additional challenges.
Management confirmed that the transition of the VA CMOP contract is expected to conclude by Memorial Day, indicating a strategic shift away from small business set-aside contracts.
Concerns were raised about the potential impact of federal health spending reprioritization, but management remains optimistic about upcoming RFPs and the overall market environment.
The company is actively evaluating its cost structure to remain competitive, with significant actions already taken to right-size operations. Overall, DLH Holdings Corp. is navigating a challenging environment but remains focused on leveraging its strengths to capitalize on emerging opportunities in the federal marketplace.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT